VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
L3Harris Technologies, Inc. vs Pfizer Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
L3Harris Technologies, Inc.
LHX · NYSE
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into L3Harris Technologies, Inc.'s moat claims, evidence, and risks.
View LHX analysisPfizer Inc.
PFE · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: L3Harris Technologies, Inc. leads (72 / 100 vs 58 / 100 for Pfizer Inc.).
- Segment focus: L3Harris Technologies, Inc. has 4 segments (31.9% in Space & Airborne Systems); Pfizer Inc. has 5 segments (47.4% in Primary Care).
- Moat breadth: L3Harris Technologies, Inc. has 8 moat types across 3 domains; Pfizer Inc. has 8 across 3.
Primary market context
L3Harris Technologies, Inc.
Space & Airborne Systems
Defense & intelligence space and airborne mission systems (payloads, sensors, avionics, mission networks)
Global (U.S.-centric demand)
Government defense/intelligence agencies, prime contractors, and allied governments
Prime contractor / subsystem integrator
31.9%
Pfizer Inc.
Primary Care
Branded primary care medicines and vaccines (incl. cardiovascular, migraine, pneumococcal/RSV/COVID-19)
Global
Healthcare providers, payers/PBMs, pharmacies/wholesalers, and government procurement
Innovator biopharma (R&D + manufacturing + commercialization)
47.4%
Side-by-side metrics
Moat coverage
Shared moat types
L3Harris Technologies, Inc. strengths
Pfizer Inc. strengths
Segment mix
L3Harris Technologies, Inc. segments
Full profile >Space & Airborne Systems
Oligopoly
Integrated Mission Systems
Oligopoly
Communication Systems
Oligopoly
Aerojet Rocketdyne
Duopoly
Pfizer Inc. segments
Full profile >Primary Care
Oligopoly
Specialty Care
Oligopoly
Oncology
Competitive
Pfizer CentreOne
Competitive
Pfizer Ignite
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.